GLIAVAX: A stratified phase II clinical trial of avelumab and axitinib in patients with recurrent glioblastoma.

Bart Neyns; Laila Ben Salama; Gil Awada; Jennifer De Cremer; Julia Katharina Schwarze; Laura Seynaeve; Stephanie Du Four; Lydia Fischbuch; Anne-Marie Vanbinst; Hendrik Everaert; Alex Michotte; Anne Rogiers; Peter Theuns; Johnny Duerinck

doi:10.1200/JCO.2019.37.15_suppl.2034

GLIAVAX: A stratified phase II clinical trial of avelumab and axitinib in patients with recurrent glioblastoma.

Bart Neyns, Laila Ben Salama, Gil Awada, Jennifer De Cremer, Julia Katharina Schwarze, Laura Seynaeve, Stephanie Du Four, Lydia Fischbuch, Anne-Marie Vanbinst, Hendrik Everaert, Alex Michotte, Anne Rogiers, Peter Theuns, Johnny Duerinck

Onderzoeksoutput: Meeting abstract (Journal)

Originele taal-2	English
Artikelnummer	2034
Tijdschrift	Journal of Clinical Oncology
Volume	37
Nummer van het tijdschrift	15
DOI's	https://doi.org/10.1200/JCO.2019.37.15_suppl.2034
Status	Published - 20 mei 2019
Evenement	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) - Chicago, United States Duur: 31 mei 2019 → 4 jun. 2019

Toegang tot document

10.1200/JCO.2019.37.15_suppl.2034Licentie: Unspecified

Citeer dit

Neyns, B., Ben Salama, L., Awada, G., De Cremer, J., Schwarze, J. K., Seynaeve, L., Du Four, S., Fischbuch, L., Vanbinst, A.-M., Everaert, H., Michotte, A., Rogiers, A., Theuns, P., & Duerinck, J. (2019). GLIAVAX: A stratified phase II clinical trial of avelumab and axitinib in patients with recurrent glioblastoma. Journal of Clinical Oncology, 37(15), Artikel 2034. https://doi.org/10.1200/JCO.2019.37.15_suppl.2034

@article{c35d8a3a65274d628ea886c4e0b12697,

title = "GLIAVAX: A stratified phase II clinical trial of avelumab and axitinib in patients with recurrent glioblastoma.",

keywords = "GLIAVAX, glioblastoma",

author = "Bart Neyns and {Ben Salama}, Laila and Gil Awada and {De Cremer}, Jennifer and Schwarze, {Julia Katharina} and Laura Seynaeve and {Du Four}, Stephanie and Lydia Fischbuch and Anne-Marie Vanbinst and Hendrik Everaert and Alex Michotte and Anne Rogiers and Peter Theuns and Johnny Duerinck",

year = "2019",

month = may,

day = "20",

doi = "10.1200/JCO.2019.37.15_suppl.2034",

language = "English",

volume = "37",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "15",

note = "Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) ; Conference date: 31-05-2019 Through 04-06-2019",

}

Neyns, B, Ben Salama, L, Awada, G , De Cremer, J , Schwarze, JK , Seynaeve, L , Du Four, S , Fischbuch, L , Vanbinst, A-M , Everaert, H , Michotte, A , Rogiers, A , Theuns, P & Duerinck, J 2019, 'GLIAVAX: A stratified phase II clinical trial of avelumab and axitinib in patients with recurrent glioblastoma.', Journal of Clinical Oncology, vol. 37, nr. 15, 2034. https://doi.org/10.1200/JCO.2019.37.15_suppl.2034

TY - JOUR

T1 - GLIAVAX: A stratified phase II clinical trial of avelumab and axitinib in patients with recurrent glioblastoma.

AU - Neyns, Bart

AU - Ben Salama, Laila

AU - Awada, Gil

AU - De Cremer, Jennifer

AU - Schwarze, Julia Katharina

AU - Seynaeve, Laura

AU - Du Four, Stephanie

AU - Fischbuch, Lydia

AU - Vanbinst, Anne-Marie

AU - Everaert, Hendrik

AU - Michotte, Alex

AU - Rogiers, Anne

AU - Theuns, Peter

AU - Duerinck, Johnny

PY - 2019/5/20

Y1 - 2019/5/20

KW - GLIAVAX

KW - glioblastoma

U2 - 10.1200/JCO.2019.37.15_suppl.2034

DO - 10.1200/JCO.2019.37.15_suppl.2034

M3 - Meeting abstract (Journal)

SN - 0732-183X

VL - 37

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 15

M1 - 2034

T2 - Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)

Y2 - 31 May 2019 through 4 June 2019

ER -